To evaluate the ability of Minnelide to regulate Mcl-1 and miR-204 levels in a preclinical setting, we analyzed Mcl-1 and miR-204 expression in three patient tumor xenografts treated with Minnelide. The gene discussed is MCL1; the disease is neoplasm.